Bookmark

Add to MyYahoo RSS

Shire plc News

News on Shire plc (Ticker: SHPGY) continually updated from thousands of sources around the net.

1 hr ago | BioSpace

Aurinia Adds Financial Expertise To Its Board Of Directors

Aurinia Pharmaceuticals Inc. today announced that Mr. Charles Rowland Jr. has joined its Board of Directors and will assume the role of Audit Committee Chair.

Comment?

Related Topix: Biotech, ViroPharma, Medicine, Healthcare Industry, Endo Pharmaceuticals Holdings

5 hrs ago | BioSpace

Shire Announces Award Recipients For 2014 Michael Yasick ADHD Scholarship

Shire plc announces the recipients of its 2014 Michael Yasick ADHD Scholarship. The program is for individuals in the United States diagnosed with Attention-Deficit/Hyperactivity Disorder who are pursuing higher education at a college, vocational school, or technical school.

Comment?

Related Topix: Medicine, ADHD, Health, Biotech, Family, Adolescents and Pre-Teens, Pennsylvania

14 hrs ago | The Spokesman-Review

Robert J. Samuelson: Solving corporate tax flight - Tue, 29 Jul 2014 PST

Corporate America's latest public relations disaster comes under the banner "tax inversion."

Comment?

Related Topix: Biotech, Social Security, Personal Finance, Healthcare Law, Law

Mon Jul 28, 2014

CFO

Another Tax Inversion Deal in the Works

The hue and cry over tax inversions is not stopping companies from proceeding with more mergers that take advantage of the tactic.

Comment?

Related Topix: Biotech

Fri Jul 25, 2014

The Washington Post

AbbVie Quarterly Profit Beats Analyst Estimates on Humira Sales

AbbVie Inc., the drugmaker that's buying Shire Plc and lowering its tax rate by moving its legal address overseas, said second-quarter profit rose 2.8 percent on strong sales of arthritis drug Humira.

Comment?

Related Topix: Biotech, Medicine, Arthritis, Health, North Chicago, IL, Business News

Wed Jul 23, 2014

Medical News

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire plc , the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy for the potential treatment of both the central nervous system and somatic manifestations in patients with ... (more)

Comment?

Related Topix: Biotech, Medicine, Health

Boston.com

JEFF JACOBYInverters aren't deserters

THE CORPORATE inversions just keep on coming, and the White House and its allies are calling them unpatriotic.

Comment?

Related Topix: US News, Prison, Biotech, US Politics, US Senate, Carl Levin, Democrat, Opinion

Mon Jul 21, 2014

AmericanBankingNews.com

Shire PLC Lowered to Neutral at Buckingham Research

Several other analysts have also recently commented on the stock. Analysts at SunTrust downgraded shares of Shire PLC from a "buy" rating to a "neutral" rating in a research note on Monday.

Comment?

Related Topix: Biotech

The Washington Post

Allergan to Cut About 1,500 Jobs to Evade Valeant Takeover

Allergan Inc., the drugmaker fending off a takeover by Valeant Pharmaceuticals International Inc., will cut 1,500 jobs and may use the savings for an acquisition, its chief executive officer said.

Comment?

Related Topix: Allergan, Biotech, AckmanZiff Real Estate Group, Financial Services, Business News

Business Wire

INVESCO Limited UK Regulatory Announcement: Form 8.3 - Shire plc

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure ... (more)

Comment?

Related Topix: Biotech

Bloomberg

Merger Rush for Offshore Tax Break Bets on U.S. Stalemate

U.S. companies are racing to complete tax-reducing offshore mergers before a credible threat to stop them emerges from Congress.

Comment?

Related Topix: US News, Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech, Salix Pharmaceuticals, US Politics, US Senate, Ron Wyden, Democrat, Orrin Hatch, Republican

Sun Jul 20, 2014

Bloomberg

Perrigo, Actelion Tax Targets Abroad for U.S. Drugmakers

Drugmakers Perrigo Co. and Actelion Ltd. , in Ireland and Switzerland , may join U.K.-based medical device company Smith & Nephew Plc as acquisition targets for U.S. health-care companies racing to find tax relief abroad before the U.S. government curbs the option.

Comment?

Related Topix: Biotech, Perrigo, Medicine, Actelion, Healthcare Industry, Actelion Pharmaceuticals, Smith and Nephew, Medical Equipment, US Politics, US News, US Senate, Ron Wyden, Democrat

Sat Jul 19, 2014

Ticker

Google Quarterly Net Nearly Matches General Electric Earnings

Bank of New York Mellon net plunged 33%. GE profit surged 13%. Google net jumped 6% and revenue soared 22%.

Comment?

Related Topix: WebMD, Emerging Technology, Search Engines, General Electric, Financial Services, Aerospace-Defense, Biotech, Bank of New York, Banking, Honeywell International

Silver City Sun-News

Glance: Biggest corporate deals so far this year

Abbvie Inc.'s deal to combine with Shire PLC would be the largest made so far this year, excluding assumed debt.

Comment?

Related Topix: Biotech, Cable & Satellite, Telecom, Time Warner Cable, Medicine, Forest Labs, Healthcare Industry, Wyoming Government, Wyoming, New York

Fri Jul 18, 2014

SFGate

AbbVie pays $54 billion for Shire

FILE PHOTO: Shire logos sit on the boxes of Elvanse 50mg tablets, produced by Shire Plc, left, and Mezavant XL 1200mg tablets, produced by Shire Plc, in this arranged photograph taken at a pharmacy in London, U.K., on Tuesday, July 8, 2014.

Comment?

Related Topix: Biotech, Business News

Insider Monkey

Shire PLC (ADR) (SHPG), Time Warner Cable (TWC): How John Paulson Got His Mojo Back

John Paulson 's funds posted strong returns in June, especially on the back of merger arbitrage plays, an activity in which Paulson has been involved for the last 20 years.

Comment?

Related Topix: Biotech, Cable & Satellite, Telecom, NaviSite, Time Warner Cable, INX, Allergan

Chicago Sun-Times

AbbVie insists Shire deal will not lead to job cuts in Chicago area

Chicago-area AbbVie Inc. employees worried about job security after the pharmaceutical firm's planned $55 billion merger with fellow drug maker Shire PLC have been told not to fret.

Comment?

Related Topix: Biotech, Insurance, AON, North Chicago, IL, Lake County, IL

Investor's Business Daily

Shire Shareholder Alert: Former Sec Attorney Willie Briscoe and...

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Shire plc concerning the buyout by AbbVie.

Comment?

Related Topix: Biotech

ABC News

Glance: Biggest Corporate Deals So Far This Year

Abbvie Inc.'s deal to combine with Shire PLC would be the largest made so far this year, excluding assumed debt.

Comment?

Related Topix: Biotech

Boston.com

AbbVie buys Lexington's Shire for $54b

Drug maker AbbVie Inc. will pay more than $54 billion for Lexington biotech Shire plc, in the largest US acquisition so far this year and a combination of two companies with substantial operations in Massachusetts.

Comment?

Related Topix: Biotech, Lexington, MA, Genetics, Medicine, Ireland, World News, Worcester, MA, Mansfield, MA

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••